• The Clorox Company reported past third-quarter 2026 results with essentially flat sales at US$1,670 million and slightly higher diluted EPS of US$1.54 from continuing operations, while nine‑month sales and earnings declined versus the prior year.
• Alongside earnings, Clorox cut its full‑year 2026 outlook, now expecting about a 6% net sales decline and a 24% to 27% drop in diluted EPS, while also filing a shelf registration for potential debt issuance as it absorbs GOJO acquisition costs and invests in digital and productivity initiatives.
• Next, we’ll examine how this reduced full‑year earnings guidance, including GOJO‑related transaction costs, may reshape Clorox’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Clorox Investment Narrative Recap

To own Clorox, you need to believe its core household brands and new assets like GOJO can convert steady demand into reliable earnings, supported by ERP and digital investments. The most important short term catalyst is whether these investments actually protect margins as inflation and competition bite. The latest guidance cut and projected EPS drop highlight that execution risk around costs and integration remains the biggest near term threat, and this update materially reinforces that concern.

The most relevant recent move here is Clorox’s updated fiscal 2026 outlook, which now calls for about a 6% sales decline and a 24% to 27% EPS drop, including GOJO transaction costs and stepped up digital and productivity spending. This reset puts more weight on the ERP and digital transformation catalyst: if those initiatives do not translate into tangible cost savings and better pricing discipline, the risk of prolonged margin pressure and weaker earnings power becomes harder to ignore.

Yet behind these headline numbers, one important cost and margin risk that investors should be aware of is...

Clorox's narrative projects $7.9 billion revenue and $911.5 million earnings by 2029. This requires 5.2% yearly revenue growth and about a $156.5 million earnings increase from $755.0 million today.

Uncover how Clorox's forecasts yield a $115.47 fair value, a 34% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts were already cautious, assuming revenue of about US$7.9 billion and earnings near US$896.7 million by 2029, and the latest guidance cut could push their view even more toward cost and margin pressure than the more balanced risk that ERP and digital gains might offset rising input and compliance costs.

Explore 7 other fair value estimates on Clorox - why the stock might be worth just $91.12!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Clorox research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Clorox research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Clorox's overall financial health at a glance.

Curious About Other Options?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
• Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.